InflaRx NV (IFRX)
1.665
-0.04
(-2.63%)
USD |
NASDAQ |
Jun 09, 16:00
1.665
0.00 (0.00%)
After-Hours: 20:00
InflaRx Total Assets (Quarterly) : 56.33M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| MediGene AG | -- |
| BioNTech SE | 24.28B |
| Immatics NV | 625.95M |
| Arrowhead Pharmaceuticals, Inc. | 2.268B |
| Oncolytics Biotech, Inc. | 8.161M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.83M |
| Shareholders Equity (Quarterly) | 42.50M |
| Debt to Equity Ratio | 0.0223 |
| Current Ratio | 4.161 |
| Net Debt Paydown Yield | 0.04% |